Metraipolis › archive › dc_bc78e87d2744
Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41388935
- DOI
- 10.1002/cam4.71469
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T01:56:43.013Z
- SHA-256 of the archived text
c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec- Stable URL of this page
https://metraipolis.com/documento/dc_bc78e87d2744
How to cite
Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935 — Europe PMC (en), https://europepmc.org/article/MED/41388935 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc78e87d2744 (Metraipolis archive dc_bc78e87d2744, sha256 c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec)
BibTeX
@misc{dcbc78e87d2744,
title = {Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter,… — Europe PMC PMID:41388935},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41388935},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc78e87d2744; sha256 c581046fa6a067f00d61f6782463a57fcc3e84532c2814e9111fb329ce519bec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41388935. Agents can read the archived copy with the MCP tool read_document.